Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
NCT00506623
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER_GOV
Sponsor class
Conditions
Rectal Neoplasm
Neoadjuvant Therapy
Interventions
DRUG:
Capecitabine, Irinotecan
Sponsor
National Cancer Center, Korea